AJANTA PHARMA LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-five approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for AJANTA PHARMA LTD
US Patents: | 0 |
Tradenames: | 55 |
Ingredients: | 54 |
NDAs: | 65 |
Drug Master File Entries: | 2 |
Drugs and US Patents for AJANTA PHARMA LTD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajanta Pharma Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 203685-002 | Dec 10, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ajanta Pharma Ltd | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216193-003 | Mar 24, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ajanta Pharma Ltd | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 208706-001 | Jan 6, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajanta Pharma Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 209654-002 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajanta Pharma Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 209859-002 | Sep 27, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.